This is the most common side effect during the first few days of use
material becomes more available to intestinal and pancreatic receptors while at lower doses, the intestinal route provides more direct exposure to the relevant receptor locations
2 Left untreated, MASH can progress to serious and even fatal outcomes, such as cirrhosis, liver cancer, and the need for liver transplant 3 Additionally, Novo Nordisk's application for Wegovy (semaglutide) injection 2.4 mg for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) was recently accepted by FDA and granted Priority Review PLAINSBORO, N.J., April 30, 2025 /PRNewswire/ -- Today, The New England Journal of Medicine (NEJM) published results from part 1 of the ongoing phase 3 ESSENCE trial which investigated the effects of once-weekly subcutaneous semaglutide 2.4 mg on liver histology compared to placebo at 72 weeks in adults with MASH and moderate to advanced liver fibrosis (stage 2 or 3)
At TrimRx, we are committed to providing individuals with effective, personalized weight loss solutions, helping you achieve your health goals while prioritizing safety and transparency
No, Ozempic is not an insulin replacement but helps improve glucose control alongside diet and lifestyle management